Anaflex 250 mg Tablet: Each enteric coated tablet contains Naproxen BP 250 mg.
Anaflex 500 mg Tablet: Each enteric coated tablet contains Naproxen BP 500 mg.
Anaflex SR 500 mg Tablet: Each tablet contains Naproxen BP 500 mg.
Anaflex Suspension: Each 5 ml contains Naproxen BP 125 mg.
Anaflex Gel: Each gram gel contains Naproxen BP 100 mg (Naproxen BP 10% w/w).
Anaflex is a preparation of Naproxen which is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory and antipyretic properties. Naproxen is a propionic acid derivative related to the acrylic acid class of drugs. It works by reducing the levels of prostaglandins, chemicals that are responsible for pain, fever and inflammation.
Route: Oral / Topical
Adults:
Children (>5 years):
Topical Gel:
Apply 2–6 times daily as needed (not recommended in children).
Warfarin and antiplatelet agents increase gastrointestinal bleeding risk; reduces renal clearance of lithium and methotrexate increasing their toxicity; ACE inhibitors, ARBs, and beta-blockers show attenuated antihypertensive efficacy; loop and thiazide diuretics show reduced natriuretic response; cyclosporine increases nephrotoxicity.
Naproxen is contraindicated in patients active peptic ulceration, hypersensitivity to naproxen or naproxen sodium formulations, aspirin or other NSAIDs.
Common: Nausea, vomiting, abdominal pain, GI bleeding, ulceration, rash, urticaria, angioedema. Less Common: Tinnitus, hearing impairment, vertigo, peripheral edema. Rare: Eosinophilic pneumonitis, thrombocytopenia, agranulocytosis, aplastic anemia, hepatitis, nephropathy, hematuria, visual disturbances, vasculitis, aseptic meningitis, ulcerative stomatitis.
Overdose
Overdose with naproxen may be characterized by drowsiness, heartbum, indigestion, nausea and vomiting. No evidences of toxicity or late sequel have been reported 5-15 months after ingestion, for three to seven days, of doses up to 3 g/day.
Category C (1st/2nd trimesters), Category D (3rd trimester). Avoid in late pregnancy due to risk of premature closure of ductus arteriosus. Lactation: Excreted in human milk; avoid during breastfeeding.
Store below 30°C in a cool, dry place. Protect from light and moisture. Keep away from children.